2019 HIGHLIGHTS compared to 2018: - Annual revenues increased by 52% - Pre-tax income of $10,701,000, an increase of $5,661,000, or 112%, compared to $5,040,000 - Net income after tax grew to $2.34 per basic share and $1.88 per diluted share, compared to $0.82 per basic share and $0.66 per diluted
SAN JOSE, Calif. , Feb. 21, 2020 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the fourth quarter and full
2019 Q3 HIGHLIGHTS compared to the corresponding period of 2018: - Revenues were $8,902,000, an increase of 60% - Pre-tax income of $3,108,000, an increase of $1,640,000, or 112%, compared to $1,468,000 - Net income grew to $1.20 per basic share and $0.96 per diluted share, compared to $0.24 per
SAN JOSE, Calif. , Oct. 23, 2019 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), an emerging growth company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the third
2019 Q2 HIGHLIGHTS compared to the corresponding period of 2018: - Revenues were $7,953,000, an increase of 45% - Net income grew to $0.41 per basic share and $0.32 per diluted share, compared to $0.24 per basic share and $0.19 per diluted share - Cash at June 30, 2019 increased to $4,182,000 from
SAN JOSE, Calif. , July 16, 2019 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), an emerging growth company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the second
SAN JOSE, Calif. , June 17, 2019 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), an emerging growth company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, announced that CEO Doug Murphy-Chutorian , M.D.
2019 Q1 HIGHLIGHTS compared to the corresponding period of 2018: - Revenue was $6,761,000, which is an increase of 51% - Net income grew to $0.29 per basic share and $0.23 per diluted share, compared to $0.12 per basic and 0.10 per diluted share - Cash at March 31, 2019 increased to $4,544,000 from
SAN JOSE, Calif. , April 18, 2019 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), an emerging growth company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the first
2018 HIGHLIGHTS compared to 2017: - Annual revenue increased by 73% - Net income after tax grew to $0.82 per basic share and $0.66 per diluted share, compared to a net loss of $0.28 per basic and diluted share - All principal and accrued interest on notes were retired - Cash at year-end increased
